Real-world outcomes of bladder carbogen and nicotinamide (BCON) in muscle-invasive bladder cancer (MIBC)
Affiliation
The Christie NHS Foundation Trust, Manchester,Issue Date
2023
Metadata
Show full item recordCitation
Lodhi T, Song YP, Elumalai T, Mistry H, Hoskin P, Choudhury A. Real-world Outcomes of Bladder Carbogen and Nicotinamide (BCON) in Muscle-invasive Bladder Cancer (MIBC). Clinical Oncology. 2023 Feb;35(2):E240-E1. PubMed PMID: WOS:001038297600018.Journal
Clinical OncologyDOI
10.1016/j.clon.2022.11.037Additional Links
https://doi.org/10.1016/j.clon.2022.11.037Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.clon.2022.11.037